Get started
Author

Mathias Schmid

Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
2011 · Max S. Topp, Peter Kufer, et al. · Journal of Clinical Oncology · 918
PDF
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)
2006 · B. Wassmann, Heike Pfeifer, et al. · Blood · 339
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
2011 · M. Lubbert, B. H. Ruter, et al. · Haematologica · 232
PDF
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia
2005 · Andrea Kuendgen, Mathias Schmid, et al. · Cancer · 221
PDF
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
2010 · Norbert Gattermann, Carlo Finelli, et al. · Leukemia Research · 175
Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
2012 · N. Gattermann, C. Finelli, et al. · Haematologica · 167
PDF
Molecular Genetic Alterations in Radiation-Induced Astrocytomas
1999 · Daniel J. Brat, C. David James, et al. · American Journal Of Pathology · 112
PDF
Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation
2005 · Hermann Heimpel, Klaus Schwarz, et al. · Blood · 110
PDF
Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC)
1998 · Mathias Schmid, Denise Malicki, et al. · Oncogene · 108
High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia.
1992 · W Digel, F Porzsolt, et al. · Journal of Clinical Investigation · 93
PDF
Protein Kinase D2 Mediates Activation of Nuclear Factor κB by Bcr-Abl in Bcr-Abl+ Human Myeloid Leukemia Cells
2004 · Tamara Mihailovic, Martin Marx, et al. · Cancer Research · 87
PDF
Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003
2010 · Dieter Hoelzer, Andreas Huettmann, et al. · Blood · 85
Polymorphism of the tumour necrosis factor‐alpha and lymphotoxin‐alpha genes in chronic lymphocytic leukaemia
1997 · Judith Demeter, Franz Porzsolt, et al. · British Journal of Haematology · 70
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma
2010 · N. Gokbuget, C.-M. Hartog, et al. · Haematologica · 64
PDF
PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003
2010 · Nicola Goekbuget, Anja Baumann, et al. · Blood · 62
A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer
2000 · Mathias Schmid, Malini Sen, et al. · Oncogene · 58
CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
2005 · Peter Liebisch, Susanne Eppinger, et al. · PubMed · 57
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17
2023 · Richard Cathomas, Sacha I. Rothschild, et al. · Journal of Clinical Oncology · 55
P53 mutations in hairy cell leukemia
2000 · EA König, WC Kusser, et al. · Leukemia · 41
Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer
2013 · Agnieszka Konieczny, Philipp Meyer, et al. · European Radiology · 39
PDF
High Survival Rate in Adult Burkitt’s Lymphoma/Leukemia and Diffuse Large B-Cell Lymphoma with Mediastinal Involvement.
2007 · Dieter Hoelzer, Wolfgang Hiddemann, et al. · Blood · 37
Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.
2009 · Dieter Hoelzer, Eckhard Thiel, et al. · Blood · 36
Cerebrospinal fluid pleocytosis: Pitfalls and benefits of combined analysis using cytomorphology and flow cytometry
2011 · Martin Bommer, Andreas Nagy, et al. · Cancer Cytopathology · 35
PDF
Long-Term Outcome of 335 Adult Patients Receiving Different Schedules of Imatinib and Chemotherapy as Front-Line Treatment for Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
2010 · Heike Pfeifer, Nicola Goekbuget, et al. · Blood · 34
Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17).
2020 · Richard Cathomas, Ulf Petrausch, et al. · Journal of Clinical Oncology · 32
Works count: 103
Citation count: 4,031
H-index: 29
I10-index: 60
Year
Topic
Type